Broughton

Are you attending ENDS 2022? Our Head of Scientific Affairs, Paul Hardman will present - Is the medicinal product pathway for ENDS in the UK an underutilized route to market? -Tuesday 24 May at @2pm. We would be delighted to meet with you to start a conversation. #ENDSEUROPE2022

Broughton gains new regulatory insight while celebrating recent PMTA success for clients. Read more here. bit.ly/39CbmIc #PMTA #FDA #Regulations #ecigarettes #smokefreefuture

FDA deadline for PMTA submissions for synthetic nicotine products is May 14th and any manufacturers that haven’t submitted their application by this deadline will be removed from the market. If you need advice about this get in touch with us. bit.ly/39NSsOm #FDA

Broughton's Toxicology Managing Consultant Dr.Tony Jones summarizes the highlights and key takeaway messages from the Respiratory Drug Delivery conference (RDD). Read more here: bit.ly/3FmVGnK #pharmaceuticals #medicinalproducts #regulations #RDD22

Broughton's Chief Scientific and Regulatory Officer Dr. Nveed Chaudhary discusses the recent FDA announcement on marketing orders and what this means for ENDS manufacturers. Read more here: bit.ly/3KIZ11J #E-cigarettes #Regulations #smokefreefuture #Nicotine

Are you interested in novel inhalation and smart delivery systems? If so, we would love to hear from you. We are attending #RDD2022 and would be delighted to meet with you to start a conversation. Find us in the RegSciTech Knowledge Space, please drop by our booth and say hello.

RDD is a premier conference focused on drug delivery to the lungs and nose. Broughton’s Chief Commercial Officer, Andy Mooney, and Toxicology Managing Consultant, Tony Jones will be attending. Find us in RegSciTech Knowledge Space please drop by our booth and say hello.#RDD2022

England aims to be smoke-free by 2030. But as a sector are we going far enough to make this happen? We discuss the positive steps English local authorities are taking to promote the benefits of alternative nicotine products: bit.ly/3kbI5pN #SmokeFreeFuture #publichealth

Are you attending The CBD Show in London tomorrow? We focus on helping companies with product development and have a special interest in novel inhalation and smart delivery systems. Our team would be delighted to meet with you, contact us here: bit.ly/3L2ZHzJ #CDB

The CBD show is an international event attracting industry, trade professionals, influencers, and exhibitors and is an excellent platform to assist you in gaining further knowledge on CBD. Attending the same conference? contact us bit.ly/3xK9qqT #CDB #Cannabis

Broughton's Toxicology Consultant, Dr. Tony Jones shares his conference highlights from Extractables and Leachables, USA. Read more here: bit.ly/3vbNSRg #extractablesandleachables

Chief Scientific and Regulatory Officer Dr. Nveed Chaudhary talks to leading sector publication Tobacco Asia about NGPs and how manufacturers can ensure their products are market-ready. Listen here: bit.ly/3js6lU4 #PMTA, #FDA, #Regulations, #smokefreefuture, #Nicotine

Our Chief Scientific and Regulatory Officer Dr. Nveed Chaudhary discusses how cannabis has huge potential as a painkiller for millions of chronic pain patients. You can read the article here: bit.ly/3DTdu9c #harmreduction #cannabis #NHS #pain

Our Toxicology Managing Consultant, Tony Jones will be attending Smithers’ Extractables and Leachables conference - April 5-7 in Arlington, USA. Attending the same conference? Contact us here: bit.ly/3J3ZSsN #extractablesandleachables #lifesciences #regulations

Broughton has published an article on the recent FDA announcement on synthetic nicotine. This article covers what this change means for manufacturers and why they need to act immediately to keep their products on the US market: bit.ly/35jjyLq #syntheticnicotine #PMTA

The US Congress set to close the loophole on the use of synthetic nicotine in Electronic Nicotine Delivery Systems (ENDS). Read more here:bit.ly/35Wao7R #PMTA #syntheticnicotine #smokefreefuture

Broughton's Head of Regulatory Affairs, Lloyd Smart, and Technical Sales Administrator, Curtis Gallagher share thoughts on emerging topics following the 27th Annual Pharmacovigilance conference: bit.ly/3KDCraO #regulation #pharmaceuticals #medicinalproducts #VIphv

Broughton's Regulatory Digest covers the latest regulatory news and updates from around the globe for the nicotine, pharmaceutical, and cannabinoids industries. Get a copy here: bit.ly/3Kihhz9 #pharmaceuticalindustry #regulations #MHRA #PMTA #FDA #Cannibinoids

Broughton's Head of Regulatory Affairs, Lloyd Smart, has recently published an article on ‘Consultation on Proposals for the Future of UK Clinical Trial Legislation’, with the leading sector publication, PharmTech: bit.ly/3vCmUE2 #Regulations #MHRA #clinicaltrials

Broughton, a global Contract Research Organization (CRO) rapidly developing its position as a full-service solutions provider to the global life sciences sector is establishing a U.S. subsidiary to enhance its presence in the region. Read more here: bit.ly/3M7S63S #news